We are live on ! Find out more
DICE

DICE Therapeutics, Inc. Common Stock

Delisted

DICE was delisted on the 8th of August, 2023.

0 hedge funds and large institutions have $0 invested in DICE Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 159 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1600 (-160)

100% less funds holding in top 10

Funds holding in top 10: 100 (-10)

100% less capital invested

Capital invested by funds: $2.11B → $0 (-$2.11B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 159

Holders
Holders Change
-160
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
159
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
76
California State Teachers Retirement System (CalSTRS)
California
-$1.77M -38,072 Closed
Barclays
77
Barclays
United Kingdom
-$1.76M -37,971 Closed
Ameriprise
78
Ameriprise
Minnesota
-$1.71M -36,775 Closed
Two Sigma Investments
79
Two Sigma Investments
New York
-$1.65M -35,600 Closed
HM
80
Harvest Management
New York
-$1.51M -32,600 Closed
VAM
81
Vazirani Asset Management
New York
-$1.39M -30,000 Closed
Legal & General Group
82
Legal & General Group
United Kingdom
-$1.38M -29,738 Closed
KC
83
Kellner Capital
New York
-$1.36M -29,200 Closed
First Trust Advisors
84
First Trust Advisors
Illinois
-$1.33M -28,677 Closed
N
85
Natixis
France
-$1.28M -27,500 Closed
State of Wisconsin Investment Board
86
State of Wisconsin Investment Board
Wisconsin
-$1.16M -25,034 Closed
Jane Street
87
Jane Street
New York
-$1.06M -22,740 Closed
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
-$1.02M -22,056 Closed
SFG
89
SVB Financial Group
Texas
-$1.01M -21,799 Closed
HS
90
HighVista Strategies
Massachusetts
-$1M -21,557 Closed
Invesco
91
Invesco
Georgia
-$997K -21,461 Closed
MIM
92
MetLife Investment Management
New Jersey
-$954K -20,543 Closed
CM
93
Crystalline Management
Canada
-$929K -20,000 Closed
DC
94
Diametric Capital
Massachusetts
-$929K -20,000 Closed
VI
95
Vestcor Inc
New Brunswick, Canada
-$929K -20,000 Closed
CC
96
Centiva Capital
New York
-$920K -19,806 Closed
BCM
97
BCK Capital Management
Connecticut
-$883K -19,000 Closed
AIG
98
American International Group
New York
-$866K -18,647 Closed
BG
99
Bellevue Group
Switzerland
-$846K -18,200 Closed
PL
100
Parkwood LLC
Ohio
-$839K -18,052 Closed

DICE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DICE Therapeutics, Inc. Common Stock (DICE) for Q3 2023, worth a combined $0 — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 159 funds closed out of DICE and 0 opened new positions — a net loss of 159 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $365M sold.

  • 0 institutional investors held DICE Therapeutics, Inc. Common Stock (DICE) as of Q3 2023, down from 160 in Q2 2023.
  • Funds reported $0 of DICE Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new DICE Therapeutics, Inc. Common Stock positions in Q3 2023 and 159 closed out, a net change of -159 holders.
  • The largest DICE Therapeutics, Inc. Common Stock seller in Q3 2023 was RA Capital Management, an estimated $365M sold.

Based on aggregated 13F filings for Q3 2023.